Field trial of a vaccine against new world cutaneous leishmaniasis in an at-risk child population: Safety, immunogenicity, and efficacy during the first 12 months of follow-up

Article

Abstract: The safety, immunogenicity, and efficacy of a vaccine against cutaneous leishmaniasis in rural Ecuad

Palabras claves:

Autores:

Aviles H., Maldonado R., Mary Margaret Weigel, Racines J.V., Rodrigo X. Armijos

Fuentes:

scopus